Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.9M Sell
161,744
-5,402
-3% -$1.7M 0.23% 91
2026
Q1
$54.9M Buy
167,146
+2,694
+2% +$967K 0.29% 79
2025
Q4
$57.8M Sell
164,452
-12,982
-7% -$4.73M 0.29% 78
2025
Q3
$65.6M Sell
177,434
-1,643
-0.9% -$635K 0.34% 70
2025
Q2
$70.9M Sell
179,077
-4,190
-2% -$1.57M 0.41% 55
2025
Q1
$68.2M Buy
183,267
+1,985
+1% +$755K 0.43% 48
2024
Q4
$65.3M Buy
181,282
+52,291
+41% +$19.4M 0.38% 62
2024
Q3
$46.6M Sell
128,991
-22,974
-15% -$7.93M 0.27% 80
2024
Q2
$51.7M Sell
151,965
-39,030
-20% -$13.2M 0.31% 71
2024
Q1
$68.4M Buy
190,995
+2,783
+1% +$936K 0.44% 49
2023
Q4
$56.4M Buy
188,212
+57,862
+44% +$16.2M 0.39% 61
2023
Q3
$35.6M Buy
130,350
+4,582
+4% +$1.31M 0.25% 83
2023
Q2
$38.4M Sell
125,768
-29,718
-19% -$8.58M 0.28% 88
2023
Q1
$40.9M Buy
155,486
+9,305
+6% +$2.47M 0.28% 84
2022
Q4
$35.7M Buy
146,181
+91,477
+167% +$20.8M 0.24% 97
2022
Q3
$11.1M Sell
54,704
-119,724
-69% -$25.2M 0.08% 243
2022
Q2
$34.7M Sell
174,428
-14,141
-7% -$3.32M 0.29% 87
2022
Q1
$50.4M Sell
188,569
-31,135
-14% -$8.06M 0.34% 69
2021
Q4
$58.8M Buy
219,704
+14,379
+7% +$3.77M 0.38% 64
2021
Q3
$54.1M Buy
205,325
+41,422
+25% +$11.1M 0.37% 60
2021
Q2
$42.6M Buy
163,903
+131,471
+405% +$33.6M 0.29% 78
2021
Q1
$7.63M Hold
32,432
0.06% 301
2020
Q4
$7.95M Sell
32,432
-11,407
-26% -$2.58M 0.06% 309
2020
Q3
$9.13M Sell
43,839
-1,021
-2% -$198K 0.09% 252
2020
Q2
$8.08M Sell
44,860
-11,439
-20% -$2.11M 0.09% 249
2020
Q1
$11.6M Hold
56,299
0.13% 184
2019
Q4
$11.8M Sell
56,299
-1,104
-2% -$229K 0.13% 186
2019
Q3
$12.4M Sell
57,403
-11,998
-17% -$2.57M 0.16% 145
2019
Q2
$15.2M Buy
69,401
+5,129
+8% +$980K 0.19% 124
2019
Q1
$12.7M Buy
64,272
+576
+0.9% +$104K 0.16% 148
2018
Q4
$9.98M Buy
63,696
+694
+1% +$116K 0.15% 158
2018
Q3
$11.2M Sell
63,002
-307
-0.5% -$52.4K 0.15% 171
2018
Q2
$10.7M Buy
63,309
+364
+0.6% +$61.2K 0.17% 157
2018
Q1
$10.1M Buy
62,945
+1,149
+2% +$185K 0.17% 159
2017
Q4
$9.57M Buy
61,796
+14,000
+29% +$2.14M 0.17% 158
2017
Q3
$6.79M Buy
47,796
+446
+0.9% +$64K 0.12% 215
2017
Q2
$6.57M Buy
47,350
+7,420
+19% +$1.02M 0.12% 198
2017
Q1
$5.26M Buy
39,930
+2,745
+7% +$347K 0.1% 241
2016
Q4
$4.46M Sell
37,185
-57,881
-61% -$6.66M 0.1% 230
2016
Q3
$11.1M Buy
95,066
+47,862
+101% +$5.58M 0.27% 95
2016
Q2
$5.66M Sell
47,204
-37,224
-44% -$4.16M 0.15% 162
2016
Q1
$9.01M Sell
84,428
-12,362
-13% -$1.22M 0.23% 119
2015
Q4
$9M Buy
96,790
+4,142
+4% +$396K 0.24% 108
2015
Q3
$8.72M Sell
92,648
-30,955
-25% -$3.07M 0.21% 138
2015
Q2
$11.8M Buy
123,603
+29,000
+31% +$2.75M 0.25% 110
2015
Q1
$8.73M Buy
94,603
+62,647
+196% +$5.83M 0.18% 160
2014
Q4
$3.01M Buy
+31,956
New +$2.83M 0.06% 305

Other funds holding SYK

Candriam SCA's SYK Position: Q2 2026 in Review

Candriam SCA reduced its Stryker (SYK) stake by 3.2% in Q2 2026, selling an estimated $1.7M and leaving 161,744 shares worth $50.9M. The position accounts for 0.23% of the portfolio, ranked #91.

Candriam SCA first reported a position in SYK in Q4 2014 and has held it in 47 quarters since. The position peaked at $70.9M in Q2 2025. 2,248 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Candriam SCA held 161,744 shares of Stryker worth $50.9M as of Q2 2026.
  • Candriam SCA sold 5,402 Stryker shares in Q2 2026, an estimated $1.7M.
  • Stryker made up 0.23% of Candriam SCA's portfolio in Q2 2026, its #91 holding.
  • Candriam SCA first reported a position in Stryker in Q4 2014 and has held it in 47 quarters since.
  • Candriam SCA's Stryker position peaked at $70.9M in Q2 2025.
  • 2,248 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.